Overexpression of hepatitis B x-interacting protein in HepG2 cells enhances tumor-induced angiogenesis
- 270 Downloads
Hepatocellular carcinoma (HCC) is a common malignancy and a leading cause of cancer death worldwide. Hepatitis B x-interacting protein (HBXIP), a cofactor of survivin, was originally identified by binding with the C-terminus of the HBx and negatively regulated the activity of HBx. In this study, the effect of HBXIP on the hepatoma cells-induced angiogenesis was investigated. Proliferation and migration of human umbilical vein endothelial cells (HUVECs) were detected by MTT and transwell assay, respectively. Tube formation and chick chorioallantoic membrane model were used to observe the angiogenesis. Vascular endothelial growth factor activity was assayed using ELISA kits. Western blotting was performed to examine the protein expression. Our results indicated that overexpression of HBXIP increased HepG2 cell-induced endothelial cells migration, proliferation, and angiogenesis, which may be related to increasing phosphorylation of endothelial NO synthase in HUVECs. These results suggest that HBXIP may play an important role in tumorigenesis by enhancing angiogenesis in HCC.
KeywordsHBXIP Hepatoma cells Angiogenesis HUVECs eNOS
- 7.Fujii R, Zhu C, Wen Y, Marusawa H, Bailly-Maitre B, Matsuzawa S, Zhang H, Kim Y, Bennett CF, Jiang W, Reed JC (2006) HBXIP, cellular target of hepatitis B virus oncoprotein, is a regulator of centrosome dynamics and cytokinesis. Cancer Res 66(18):9099–9107. doi:10.1158/0008-5472.CAN-06-1886 PubMedCrossRefGoogle Scholar
- 14.Tang J, Wang J, Zheng F, Kong X, Guo L, Yang J, Zhang L, Huang Y (2010) Combination of chemokine and angiogenic factor genes and mesenchymal stem cells could enhance angiogenesis and improve cardiac function after acute myocardial infarction in rats. Mol Cell Biochem 339(1–2):107–118. doi:10.1007/s11010-009-0374-0 PubMedCrossRefGoogle Scholar
- 17.Daher Z, Boulay PL, Desjardins F, Gratton JP, Claing A (2010) Vascular endothelial growth factor receptor-2 activates ADP-ribosylation factor 1 to promote endothelial nitric-oxide synthase activation and nitric oxide release from endothelial cells. J Biol Chem 285(32):24591–24599. doi:10.1074/jbc.M110.115311 PubMedCrossRefGoogle Scholar
- 20.Qin J, Chen X, Yu-Lee LY, Tsai MJ, Tsai SY (2010) Nuclear receptor COUP-TFII controls pancreatic islet tumor angiogenesis by regulating vascular endothelial growth factor/vascular endothelial growth factor receptor-2 signaling. Cancer Res 70(21):8812–8821. doi:10.1158/0008-5472.CAN-10-0551 PubMedCrossRefGoogle Scholar